Literature DB >> 16351379

Clinical utility: a prerequisite for the adoption of a dimensional approach in DSM.

Michael B First1.   

Abstract

A potential obstacle to implementing dimensional representations in the Diagnostic and Statistical Manual of Mental Disorders (DSM) is lack of data about clinical utility and user acceptability. Adopting a dimensional approach would likely complicate medical record keeping, create administrative and clinical barriers between mental disorders and medical conditions, require a massive retreating effort, disrupt research efforts (e.g., meta-analyses), and complicate clinicians' efforts to integrate prior clinical research using DSM categories into clinical practice. Efforts to empirically demonstrate the clinical utility of dimensional alternatives should be a prerequisite for their future implementation in order to establish that their advantages outweigh the disadvantages. Approaches to promote user acceptability and the development of an empirical database include dimensionalizing existing DSM categories and including research dimensions in the DSM appendix. Copyright (c) 2005 APA, all rights reserved.

Entities:  

Mesh:

Year:  2005        PMID: 16351379     DOI: 10.1037/0021-843X.114.4.560

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  30 in total

1.  Global Assessment of Functioning (GAF): properties and frontier of current knowledge.

Authors:  I H Monrad Aas
Journal:  Ann Gen Psychiatry       Date:  2010-05-07       Impact factor: 3.455

Review 2.  A brief taxometrics primer.

Authors:  Theodore P Beauchaine
Journal:  J Clin Child Adolesc Psychol       Date:  2007 Oct-Dec

3.  Linking antisocial behavior, substance use, and personality: an integrative quantitative model of the adult externalizing spectrum.

Authors:  Robert F Krueger; Kristian E Markon; Christopher J Patrick; Stephen D Benning; Mark D Kramer
Journal:  J Abnorm Psychol       Date:  2007-11

Review 4.  DSM categories and dimensions in clinical and research contexts.

Authors:  Helena Chmura Kraemer
Journal:  Int J Methods Psychiatr Res       Date:  2007       Impact factor: 4.035

5.  An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses.

Authors:  A Carlo Altamura; Marta Serati; Alessandra Albano; Riccardo A Paoli; Ira D Glick; Bernardo Dell'Osso
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-02-18       Impact factor: 5.270

6.  Initial interpretation and evaluation of a profile-based classification system for the anxiety and mood disorders: Incremental validity compared to DSM-IV categories.

Authors:  Anthony J Rosellini; Timothy A Brown
Journal:  Psychol Assess       Date:  2014-09-29

7.  Data-Driven Phenotypic Categorization for Neurobiological Analyses: Beyond DSM-5 Labels.

Authors:  Nicholas T Van Dam; David O'Connor; Enitan T Marcelle; Erica J Ho; R Cameron Craddock; Russell H Tobe; Vilma Gabbay; James J Hudziak; F Xavier Castellanos; Bennett L Leventhal; Michael P Milham
Journal:  Biol Psychiatry       Date:  2016-07-19       Impact factor: 13.382

8.  Can clinicians recognize DSM-IV personality disorders from five-factor model descriptions of patient cases?

Authors:  Benjamin M Rottman; Woo-Kyoung Ahn; Charles A Sanislow; Nancy S Kim
Journal:  Am J Psychiatry       Date:  2009-03-16       Impact factor: 18.112

Review 9.  A proposal for a dimensional classification system based on the shared features of the DSM-IV anxiety and mood disorders: implications for assessment and treatment.

Authors:  Timothy A Brown; David H Barlow
Journal:  Psychol Assess       Date:  2009-09

Review 10.  On the value of homogeneous constructs for construct validation, theory testing, and the description of psychopathology.

Authors:  Gregory T Smith; Denis M McCarthy; Tamika C B Zapolski
Journal:  Psychol Assess       Date:  2009-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.